OrbiMed’s Braveheart Bio BRVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$246M Buy
+12,175,159
New +$321M 4.47% 5

Other funds holding BRVE

OrbiMed's BRVE Position: Q3 2026 in Review

OrbiMed opened a new position in Braveheart Bio (BRVE) in Q3 2026: 12,175,159 shares worth $246M. The stake represents 4.47% of the portfolio and ranks #5 among its holdings.

64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.

  • OrbiMed held 12,175,159 shares of Braveheart Bio worth $246M as of Q3 2026.
  • Braveheart Bio was a new OrbiMed position in Q3 2026.
  • Braveheart Bio made up 4.47% of OrbiMed's portfolio in Q3 2026, its #5 holding.
  • 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.